vs

Side-by-side financial comparison of Nutex Health, Inc. (NUTX) and PARK NATIONAL CORP (PRK). Click either name above to swap in a different company.

PARK NATIONAL CORP is the larger business by last-quarter revenue ($168.3M vs $151.7M, roughly 1.1× Nutex Health, Inc.). PARK NATIONAL CORP runs the higher net margin — 25.3% vs 7.8%, a 17.5% gap on every dollar of revenue. On growth, PARK NATIONAL CORP posted the faster year-over-year revenue change (2.2% vs -41.1%). PARK NATIONAL CORP produced more free cash flow last quarter ($191.9M vs $69.0M). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 4.9%).

Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.

National Retail Systems, Inc. (NRS) includes Keystone Freight Corp. & National Retail Transportation, Inc. (NRT). NRS is an asset based 3PL founded in 1952. It is headquartered in Lyndhurst, New Jersey, United States.

NUTX vs PRK — Head-to-Head

Bigger by revenue
PRK
PRK
1.1× larger
PRK
$168.3M
$151.7M
NUTX
Growing faster (revenue YoY)
PRK
PRK
+43.3% gap
PRK
2.2%
-41.1%
NUTX
Higher net margin
PRK
PRK
17.5% more per $
PRK
25.3%
7.8%
NUTX
More free cash flow
PRK
PRK
$123.0M more FCF
PRK
$191.9M
$69.0M
NUTX
Faster 2-yr revenue CAGR
NUTX
NUTX
Annualised
NUTX
50.0%
4.9%
PRK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NUTX
NUTX
PRK
PRK
Revenue
$151.7M
$168.3M
Net Profit
$11.8M
$42.6M
Gross Margin
30.4%
Operating Margin
20.4%
Net Margin
7.8%
25.3%
Revenue YoY
-41.1%
2.2%
Net Profit YoY
-80.8%
10.4%
EPS (diluted)
$2.34
$2.62

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NUTX
NUTX
PRK
PRK
Q4 25
$151.7M
$168.3M
Q3 25
$267.8M
$169.5M
Q2 25
$244.0M
$168.7M
Q1 25
$211.8M
$157.9M
Q4 24
$257.6M
$164.7M
Q3 24
$78.8M
$170.3M
Q2 24
$76.1M
$157.7M
Q1 24
$67.5M
$152.8M
Net Profit
NUTX
NUTX
PRK
PRK
Q4 25
$11.8M
$42.6M
Q3 25
$55.4M
$47.2M
Q2 25
$-17.7M
$48.1M
Q1 25
$21.2M
$42.2M
Q4 24
$61.6M
$38.6M
Q3 24
$-8.8M
$38.2M
Q2 24
$-364.0K
$39.4M
Q1 24
$-364.0K
$35.2M
Gross Margin
NUTX
NUTX
PRK
PRK
Q4 25
30.4%
Q3 25
57.8%
Q2 25
51.2%
Q1 25
55.9%
Q4 24
55.0%
Q3 24
27.8%
Q2 24
29.7%
Q1 24
15.1%
Operating Margin
NUTX
NUTX
PRK
PRK
Q4 25
20.4%
Q3 25
48.7%
34.3%
Q2 25
13.8%
35.2%
Q1 25
38.1%
32.4%
Q4 24
44.4%
Q3 24
12.3%
27.4%
Q2 24
7.0%
30.6%
Q1 24
2.1%
27.8%
Net Margin
NUTX
NUTX
PRK
PRK
Q4 25
7.8%
25.3%
Q3 25
20.7%
27.8%
Q2 25
-7.3%
28.5%
Q1 25
10.0%
26.7%
Q4 24
23.9%
23.5%
Q3 24
-11.2%
22.4%
Q2 24
-0.5%
25.0%
Q1 24
-0.5%
23.0%
EPS (diluted)
NUTX
NUTX
PRK
PRK
Q4 25
$2.34
$2.62
Q3 25
$7.76
$2.92
Q2 25
$-2.95
$2.97
Q1 25
$3.33
$2.60
Q4 24
$11.56
$2.38
Q3 24
$-1.72
$2.35
Q2 24
$-0.07
$2.42
Q1 24
$-0.08
$2.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NUTX
NUTX
PRK
PRK
Cash + ST InvestmentsLiquidity on hand
$185.6M
$233.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$329.4M
$1.4B
Total Assets
$918.5M
$9.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NUTX
NUTX
PRK
PRK
Q4 25
$185.6M
$233.5M
Q3 25
$166.0M
$218.9M
Q2 25
$96.7M
$193.1M
Q1 25
$84.7M
$237.6M
Q4 24
$40.6M
$160.6M
Q3 24
$46.9M
$201.7M
Q2 24
$40.8M
$261.5M
Q1 24
$30.0M
$306.1M
Stockholders' Equity
NUTX
NUTX
PRK
PRK
Q4 25
$329.4M
$1.4B
Q3 25
$317.2M
$1.3B
Q2 25
$235.3M
$1.3B
Q1 25
$176.9M
$1.3B
Q4 24
$132.4M
$1.2B
Q3 24
$60.4M
$1.2B
Q2 24
$62.7M
$1.2B
Q1 24
$63.0M
$1.2B
Total Assets
NUTX
NUTX
PRK
PRK
Q4 25
$918.5M
$9.8B
Q3 25
$964.5M
$9.9B
Q2 25
$841.0M
$9.9B
Q1 25
$761.9M
$9.9B
Q4 24
$655.3M
$9.8B
Q3 24
$438.5M
$9.9B
Q2 24
$422.4M
$9.9B
Q1 24
$404.3M
$9.9B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NUTX
NUTX
PRK
PRK
Operating Cash FlowLast quarter
$70.4M
$198.3M
Free Cash FlowOCF − Capex
$69.0M
$191.9M
FCF MarginFCF / Revenue
45.5%
114.1%
Capex IntensityCapex / Revenue
0.9%
3.8%
Cash ConversionOCF / Net Profit
5.95×
4.65×
TTM Free Cash FlowTrailing 4 quarters
$245.6M
$328.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NUTX
NUTX
PRK
PRK
Q4 25
$70.4M
$198.3M
Q3 25
$99.5M
$52.6M
Q2 25
$27.3M
$49.7M
Q1 25
$51.0M
$37.9M
Q4 24
$54.0K
$178.8M
Q3 24
$6.8M
$43.8M
Q2 24
$13.3M
$50.9M
Q1 24
$3.1M
$35.0M
Free Cash Flow
NUTX
NUTX
PRK
PRK
Q4 25
$69.0M
$191.9M
Q3 25
$99.2M
$51.1M
Q2 25
$26.5M
$48.4M
Q1 25
$50.9M
$36.8M
Q4 24
$-341.0K
$169.7M
Q3 24
$6.2M
$41.7M
Q2 24
$12.7M
$49.0M
Q1 24
$2.3M
$31.9M
FCF Margin
NUTX
NUTX
PRK
PRK
Q4 25
45.5%
114.1%
Q3 25
37.0%
30.1%
Q2 25
10.9%
28.7%
Q1 25
24.0%
23.3%
Q4 24
-0.1%
103.0%
Q3 24
7.8%
24.5%
Q2 24
16.7%
31.1%
Q1 24
3.4%
20.8%
Capex Intensity
NUTX
NUTX
PRK
PRK
Q4 25
0.9%
3.8%
Q3 25
0.1%
0.9%
Q2 25
0.3%
0.8%
Q1 25
0.0%
0.7%
Q4 24
0.2%
5.6%
Q3 24
0.8%
1.2%
Q2 24
0.7%
1.2%
Q1 24
1.1%
2.1%
Cash Conversion
NUTX
NUTX
PRK
PRK
Q4 25
5.95×
4.65×
Q3 25
1.80×
1.11×
Q2 25
1.03×
Q1 25
2.40×
0.90×
Q4 24
0.00×
4.63×
Q3 24
1.14×
Q2 24
1.29×
Q1 24
0.99×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NUTX
NUTX

Hospital Division$143.7M95%
Population Health Management Division$8.0M5%

PRK
PRK

Segment breakdown not available.

Related Comparisons